Yes. Since you want to use this as a **learning prompt for ER stroke management**, I would make the prompt explicitly ask for **current, guideline-based, clinically practical information**, while separating what can and cannot be diagnosed from the information you currently have. For your case, the information currently supports **suspected acute stroke with severe left hemiplegia and dysarthria**, but **ischemic vs hemorrhagic stroke cannot be determined clinically with certainty**. Non-contrast CT head is the key initial investigation to distinguish hemorrhage from ischemia and to guide reperfusion decisions. The 2026 AHA/ASA acute ischemic stroke guideline emphasizes rapid treatment of eligible patients and currently recommends IV thrombolysis with either tenecteplase 0.25 mg/kg (maximum 25 mg) or alteplase 0.9 mg/kg in appropriate patients within 4.5 hours; thrombectomy eligibility depends on vessel occlusion, imaging and time window. ([AHA Journals][1]) The AHA/ASA ICH guideline emphasizes rapid neuroimaging, BP control, anticoagulant reversal when applicable, and transfer to centers with neurocritical/neurosurgical capability when required. ([AHA Journals][2]) Here is a **copy-paste prompt** designed to generate approximately **1,900 words** of high-quality learning notes: You are an experienced stroke physician, emergency medicine physician, and medical educator. Prepare a comprehensive, clinically practical, evidence-based learning note of approximately 1,900 words for a medical officer working in an Emergency Department. The topic is: **ACUTE STROKE IN THE EMERGENCY DEPARTMENT: ISCHEMIC VS HEMORRHAGIC STROKE — PRESENTATION, INITIAL MANAGEMENT, INVESTIGATION, DEFINITIVE MANAGEMENT, MONITORING, AND REFERRAL** Use the most recent available major international guidelines and high-quality evidence. Prioritize the **2026 AHA/ASA Guideline for Early Management of Acute Ischemic Stroke**, the **2022 AHA/ASA Guideline for Spontaneous Intracerebral Hemorrhage**, and other current major stroke guidelines where relevant. Clearly mention the guideline/year when giving important treatment recommendations. Do not rely on outdated protocols when newer recommendations are available. This is an educational clinical-management note, not a substitute for local hospital protocol, neurologist consultation, or specialist decision-making. ## CASE TO ANALYZE A 75-year-old male presented to the Emergency Department with: * Sudden/acute left-sided body weakness * Slurred speech * Power approximately 0/5 in the left upper limb * Power approximately 0/5 in the left lower limb * Patient was referred to a higher medical center for CT scan of the head Important information that is currently NOT available: * Exact time of symptom onset / last known well * Blood pressure * Pulse and rhythm * Oxygen saturation * Blood glucose * GCS * NIHSS score * Pupillary findings * Facial weakness * Sensory findings * Aphasia vs dysarthria * Visual field findings * Ataxia * Previous stroke/TIA * Hypertension * Diabetes * Atrial fibrillation * Ischemic heart disease * Antiplatelet use * Anticoagulant use * Recent surgery or bleeding * Seizure * Head trauma * Baseline functional status * CT findings Therefore, do NOT falsely label the case as ischemic or hemorrhagic stroke before imaging. ## PART 1 — CLINICAL DIAGNOSIS OF THIS PATIENT Based only on the information provided, explain: 1. What is the most appropriate preliminary diagnosis? 2. What neurological syndrome does left-sided complete hemiplegia with dysarthria suggest? 3. Which side of the brain is most likely affected and why? 4. What vascular territories should be considered, especially MCA/internal capsule/basal ganglia? 5. Can ischemic stroke and hemorrhagic stroke be reliably distinguished clinically? 6. What important stroke mimics should be considered? 7. What additional history and examination are immediately required? Give the diagnosis in appropriate clinical terminology, for example: **“Suspected acute cerebrovascular accident presenting with severe left hemiplegia and dysarthria — stroke subtype pending urgent neuroimaging.”** Do not call it “ischemic stroke” or “hemorrhagic stroke” unless imaging supports that diagnosis. ## PART 2 — FIRST 10–15 MINUTES IN THE ER Create a practical ER algorithm beginning from the moment the patient arrives. Organize it as: **ABCDE → glucose → neurological assessment → stroke timing → BP → IV access → blood tests → urgent brain imaging → reperfusion decision** Explain what the medical officer should actually do at the bedside. Include: * Airway assessment * Breathing and oxygenation * Circulation * Cardiac monitoring * Two IV lines where appropriate * Capillary blood glucose * Temperature * Blood pressure * Oxygen saturation * GCS * Pupils * Focused neurological examination * NIHSS * Last-known-well time * Medication history * Anticoagulant/antiplatelet history * Recent surgery/bleeding * Baseline functional status * Seizure history Explain which actions should NOT delay urgent brain imaging or reperfusion assessment. ## PART 3 — ISCHEMIC VS HEMORRHAGIC STROKE Create a clear comparison table with: * Pathophysiology * Typical presentation * Headache * Vomiting * Level of consciousness * Focal neurological deficit * Seizure * Blood pressure * CT findings * MRI findings * Initial treatment * BP approach * Antiplatelet use * Anticoagulation * Thrombolysis * Mechanical thrombectomy * Neurosurgical role * Major complications Clearly state that clinical findings overlap and imaging is required. ## PART 4 — INVESTIGATIONS Explain the investigations in the correct order. ### Immediate investigations Discuss: * Non-contrast CT head * CT angiography * CT perfusion when appropriate * MRI brain/DWI when appropriate * ECG * Cardiac monitoring ### Laboratory investigations Discuss: * CBC/platelets * Blood glucose * Electrolytes * Renal function * Liver function where relevant * PT/INR * aPTT * Troponin when clinically indicated * Blood group/type and screen when appropriate Explain which investigations are mandatory before thrombolysis and which should not unnecessarily delay treatment when eligibility can otherwise be established. Explain what the CT scan should specifically look for: * Intracranial hemorrhage * Early ischemic changes * Large established infarction * Hyperdense artery sign * Mass effect * Midline shift * Hydrocephalus * Other structural causes Explain ASPECTS and when CTA is important for detecting large-vessel occlusion. ## PART 5 — ACUTE ISCHEMIC STROKE MANAGEMENT Create a decision pathway: **CT shows no hemorrhage → determine time from last known well → assess IV thrombolysis eligibility → assess large-vessel occlusion → assess thrombectomy eligibility** Explain: ### A. IV thrombolysis Discuss current recommendations for: * Tenecteplase * Alteplase * Standard doses * Maximum doses * Standard treatment window * Selected extended-window situations * Important contraindications * BP requirements before treatment * BP monitoring after treatment * What to do if neurological deterioration occurs * Management of symptomatic intracranial hemorrhage after thrombolysis Make dosing and BP targets very clear. ### B. Mechanical thrombectomy Explain: * Large-vessel occlusion * ICA/M1 and relevant posterior circulation situations * CTA requirement * Time windows * Imaging selection * NIHSS considerations * Pre-stroke functional status * Why thrombectomy should not be delayed unnecessarily * Relationship between IV thrombolysis and thrombectomy Explain that eligible patients may receive IV thrombolysis and thrombectomy rather than choosing one instead of the other. ### C. Patients NOT receiving reperfusion therapy Discuss: * Aspirin timing * BP management * Hydration * Glucose * Temperature * Swallow assessment * DVT prevention * Oxygen * Nutrition * Early rehabilitation Clearly explain when aspirin should NOT be given. ## PART 6 — ACUTE INTRACEREBRAL HEMORRHAGE MANAGEMENT If CT demonstrates intracerebral hemorrhage, create a separate management algorithm. Discuss: 1. ABC stabilization 2. Neurocritical care/stroke-unit admission 3. BP management 4. Repeat neurological assessment 5. Anticoagulant reversal 6. Antiplatelet considerations 7. Neurosurgical consultation 8. ICP management when indicated 9. Hydrocephalus 10. Cerebellar hemorrhage 11. Intraventricular hemorrhage 12. Seizures 13. DVT prophylaxis 14. Repeat CT imaging 15. Nutrition and swallowing 16. Rehabilitation Explain anticoagulant reversal according to the specific drug: * Warfarin * Dabigatran * Apixaban * Rivaroxaban * Other factor Xa inhibitors Do not recommend routine therapies that current guidelines show are ineffective or harmful. ## PART 7 — BLOOD PRESSURE MANAGEMENT Create a separate practical table: **Situation → BP threshold/target → treatment approach** Include: * Suspected ischemic stroke without reperfusion * Ischemic stroke eligible for thrombolysis * Before thrombolysis * After thrombolysis * Before thrombectomy * After thrombectomy * Intracerebral hemorrhage * BP requiring treatment because of another emergency such as aortic dissection, ACS, pulmonary edema, etc. Explain why excessive BP reduction can worsen cerebral ischemia. ## PART 8 — MONITORING IN THE ER AND STROKE UNIT Create a monitoring checklist covering: * BP frequency * Neurological assessment * GCS * NIHSS * Pupils * Oxygen saturation * Heart rhythm * Glucose * Temperature * Fluid balance * Urine output * Swallowing * Aspiration * Cerebral edema * Neurological deterioration * Seizure * Recurrent stroke * Hemorrhagic transformation * DVT/PE * Pressure injuries Give special monitoring instructions after IV thrombolysis. ## PART 9 — COMPLICATIONS Discuss major early complications of ischemic and hemorrhagic stroke: * Cerebral edema * Herniation * Hemorrhagic transformation * Aspiration pneumonia * Dysphagia * Seizure * DVT/PE * Arrhythmia * Acute coronary syndrome * Hyperglycemia/hypoglycemia * Fever * Pressure sores * Urinary complications For each, explain what the ER/ward medical officer should recognize and do initially. ## PART 10 — REFERRAL AND TRANSFER Since the described patient was referred to a higher center for CT, explain: * When transfer is appropriate * What must be stabilized before transfer * What information should accompany the patient * Why “time last known well” is critical * Medication history * Anticoagulant history * BP * GCS/NIHSS * Blood glucose * IV access * Imaging availability * Need for stroke/neurosurgical/neurointerventional capability Create a concise **stroke transfer checklist**. ## PART 11 — APPLY THE KNOWLEDGE TO THIS 75-YEAR-OLD PATIENT Give a case-specific analysis. Use only the facts supplied. State: ### Most likely preliminary diagnosis: Suspected acute stroke with severe left hemiplegia and dysarthria, subtype not yet determined. Then explain: * Why this is a medical emergency * What information is missing * What examination should be performed * What should be done immediately * Why CT is urgent * What findings would indicate ischemic stroke * What findings would indicate hemorrhagic stroke * What would determine thrombolysis eligibility * What would determine thrombectomy eligibility * What would require neurosurgical referral Do not invent BP, NIHSS, onset time, CT findings, or comorbidities. ## PART 12 — FINAL ER FLOWCHART Finish with a compact practical algorithm: **SUSPECTED STROKE** ↓ **ABC + glucose + vitals + IV access + cardiac monitoring** ↓ **Determine last-known-well** ↓ **NIHSS + focused neurological examination** ↓ **Urgent non-contrast CT ± CTA** ↓ **HEMORRHAGE?** If YES: → ICH pathway → BP control → anticoagulant reversal if indicated → neurosurgery/neurocritical care → repeat imaging/monitoring If NO: → Ischemic stroke pathway → assess thrombolysis eligibility → assess LVO/thrombectomy eligibility → reperfusion if eligible → antiplatelet and secondary prevention when appropriate → stroke-unit care ## IMPORTANT SAFETY REQUIREMENTS 1. Do not invent missing clinical information. 2. Clearly distinguish “suspected diagnosis” from “confirmed diagnosis.” 3. Use current guideline-based recommendations. 4. Give exact drug doses only when supported by current guidelines. 5. Clearly state contraindications and important exceptions. 6. Highlight time-sensitive decisions. 7. Do not recommend aspirin before hemorrhage has been excluded. 8. Do not recommend thrombolysis before appropriate brain imaging and eligibility assessment. 9. Do not delay reperfusion therapy unnecessarily for investigations that are not required. 10. Clearly explain that local stroke-center protocols may differ and specialist consultation is required. 11. Highlight situations requiring immediate neurology, neurosurgery, or neurointerventional consultation. 12. Include references to the major guidelines used. 13. Make the final note useful to a medical officer working in a resource-limited Emergency Department, including what to do when CT is available only at a higher referral center. Use clear headings, tables, algorithms, bullet points, and practical bedside language.

Reading File
Searching the Web

2023 AHA/ASA guideline early management acute ischemic stroke tenecteplase alteplase dose update 2024 2025 2026

Searching PubMed

"acute ischemic stroke" AND "guideline"

You are an experienced stroke physician, emergency medicine physician, and medical educator. Prepare a comprehensive, clinically practical, evidence-based learning note for a medical officer working in an Emergency Department. The topic is: **ACUTE STROKE IN THE EMERGENCY DEPARTMENT: ISCHEMIC VS HEMORRHAGIC STROKE — PRESENTATION, INITIAL MANAGEMENT, INVESTIGATION, DEFINITIVE MANAGEMENT, MONITORING, AND REFERRAL** Use the most recent available major international guidelines and high-quality evidence. Prioritize the **2026 AHA/ASA Guideline for Early Management of Acute Ischemic Stroke**, the **2022 AHA/ASA Guideline for Spontaneous Intracerebral Hemorrhage**, and other current major stroke guidelines where relevant. Clearly mention the guideline/year when giving important treatment recommendations. Do not rely on outdated protocols when newer recommendations are available. This is an educational clinical-management note, not a substitute for local hospital protocol, neurologist consultation, or specialist decision-making. ## CASE TO ANALYZE A 75-year-old male presented to the Emergency Department with: * Sudden/acute left-sided body weakness * Slurred speech * Power approximately 0/5 in the left upper limb * Power approximately 0/5 in the left lower limb * Patient was referred to a higher medical center for CT scan of the head Important information that is currently NOT available: * Exact time of symptom onset / last known well * Blood pressure * Pulse and rhythm * Oxygen saturation * Blood glucose * GCS * NIHSS score * Pupillary findings * Facial weakness * Sensory findings * Aphasia vs dysarthria * Visual field findings * Ataxia * Previous stroke/TIA * Hypertension * Diabetes * Atrial fibrillation * Ischemic heart disease * Antiplatelet use * Anticoagulant use * Recent surgery or bleeding * Seizure * Head trauma * Baseline functional status * CT findings Therefore, do NOT falsely label the case as ischemic or hemorrhagic stroke before imaging. ## PART 1 — CLINICAL DIAGNOSIS OF THIS PATIENT Based only on the information provided, explain: 1. What is the most appropriate preliminary diagnosis? 2. What neurological syndrome does left-sided complete hemiplegia with dysarthria suggest? 3. Which side of the brain is most likely affected and why? 4. What vascular territories should be considered, especially MCA/internal capsule/basal ganglia? 5. Can ischemic stroke and hemorrhagic stroke be reliably distinguished clinically? 6. What important stroke mimics should be considered? 7. What additional history and examination are immediately required? Give the diagnosis in appropriate clinical terminology, for example: **“Suspected acute cerebrovascular accident presenting with severe left hemiplegia and dysarthria — stroke subtype pending urgent neuroimaging.”** Do not call it “ischemic stroke” or “hemorrhagic stroke” unless imaging supports that diagnosis. ## PART 2 — FIRST 10–15 MINUTES IN THE ER Create a practical ER algorithm beginning from the moment the patient arrives. Organize it as: **ABCDE → glucose → neurological assessment → stroke timing → BP → IV access → blood tests → urgent brain imaging → reperfusion decision** Explain what the medical officer should actually do at the bedside. Include: * Airway assessment * Breathing and oxygenation * Circulation * Cardiac monitoring * Two IV lines where appropriate * Capillary blood glucose * Temperature * Blood pressure * Oxygen saturation * GCS * Pupils * Focused neurological examination * NIHSS * Last-known-well time * Medication history * Anticoagulant/antiplatelet history * Recent surgery/bleeding * Baseline functional status * Seizure history Explain which actions should NOT delay urgent brain imaging or reperfusion assessment. ## PART 3 — ISCHEMIC VS HEMORRHAGIC STROKE Create a clear comparison table with: * Pathophysiology * Typical presentation * Headache * Vomiting * Level of consciousness * Focal neurological deficit * Seizure * Blood pressure * CT findings * MRI findings * Initial treatment * BP approach * Antiplatelet use * Anticoagulation * Thrombolysis * Mechanical thrombectomy * Neurosurgical role * Major complications Clearly state that clinical findings overlap and imaging is required. ## PART 4 — INVESTIGATIONS Explain the investigations in the correct order. ### Immediate investigations Discuss: * Non-contrast CT head * CT angiography * CT perfusion when appropriate * MRI brain/DWI when appropriate * ECG * Cardiac monitoring ### Laboratory investigations Discuss: * CBC/platelets * Blood glucose * Electrolytes * Renal function * Liver function where relevant * PT/INR * aPTT * Troponin when clinically indicated * Blood group/type and screen when appropriate Explain which investigations are mandatory before thrombolysis and which should not unnecessarily delay treatment when eligibility can otherwise be established. Explain what the CT scan should specifically look for: * Intracranial hemorrhage * Early ischemic changes * Large established infarction * Hyperdense artery sign * Mass effect * Midline shift * Hydrocephalus * Other structural causes Explain ASPECTS and when CTA is important for detecting large-vessel occlusion. ## PART 5 — ACUTE ISCHEMIC STROKE MANAGEMENT Create a decision pathway: **CT shows no hemorrhage → determine time from last known well → assess IV thrombolysis eligibility → assess large-vessel occlusion → assess thrombectomy eligibility** Explain: ### A. IV thrombolysis Discuss current recommendations for: * Tenecteplase * Alteplase * Standard doses * Maximum doses * Standard treatment window * Selected extended-window situations * Important contraindications * BP requirements before treatment * BP monitoring after treatment * What to do if neurological deterioration occurs * Management of symptomatic intracranial hemorrhage after thrombolysis Make dosing and BP targets very clear. ### B. Mechanical thrombectomy Explain: * Large-vessel occlusion * ICA/M1 and relevant posterior circulation situations * CTA requirement * Time windows * Imaging selection * NIHSS considerations * Pre-stroke functional status * Why thrombectomy should not be delayed unnecessarily * Relationship between IV thrombolysis and thrombectomy Explain that eligible patients may receive IV thrombolysis and thrombectomy rather than choosing one instead of the other. ### C. Patients NOT receiving reperfusion therapy Discuss: * Aspirin timing * BP management * Hydration * Glucose * Temperature * Swallow assessment * DVT prevention * Oxygen * Nutrition * Early rehabilitation Clearly explain when aspirin should NOT be given. ## PART 6 — ACUTE INTRACEREBRAL HEMORRHAGE MANAGEMENT If CT demonstrates intracerebral hemorrhage, create a separate management algorithm. Discuss: 1. ABC stabilization 2. Neurocritical care/stroke-unit admission 3. BP management 4. Repeat neurological assessment 5. Anticoagulant reversal 6. Antiplatelet considerations 7. Neurosurgical consultation 8. ICP management when indicated 9. Hydrocephalus 10. Cerebellar hemorrhage 11. Intraventricular hemorrhage 12. Seizures 13. DVT prophylaxis 14. Repeat CT imaging 15. Nutrition and swallowing 16. Rehabilitation Explain anticoagulant reversal according to the specific drug: * Warfarin * Dabigatran * Apixaban * Rivaroxaban * Other factor Xa inhibitors Do not recommend routine therapies that current guidelines show are ineffective or harmful. ## PART 7 — BLOOD PRESSURE MANAGEMENT Create a separate practical table: **Situation → BP threshold/target → treatment approach** Include: * Suspected ischemic stroke without reperfusion * Ischemic stroke eligible for thrombolysis * Before thrombolysis * After thrombolysis * Before thrombectomy * After thrombectomy * Intracerebral hemorrhage * BP requiring treatment because of another emergency such as aortic dissection, ACS, pulmonary edema, etc. Explain why excessive BP reduction can worsen cerebral ischemia. ## PART 8 — MONITORING IN THE ER AND STROKE UNIT Create a monitoring checklist covering: * BP frequency * Neurological assessment * GCS * NIHSS * Pupils * Oxygen saturation * Heart rhythm * Glucose * Temperature * Fluid balance * Urine output * Swallowing * Aspiration * Cerebral edema * Neurological deterioration * Seizure * Recurrent stroke * Hemorrhagic transformation * DVT/PE * Pressure injuries Give special monitoring instructions after IV thrombolysis. ## PART 9 — COMPLICATIONS Discuss major early complications of ischemic and hemorrhagic stroke: * Cerebral edema * Herniation * Hemorrhagic transformation * Aspiration pneumonia * Dysphagia * Seizure * DVT/PE * Arrhythmia * Acute coronary syndrome * Hyperglycemia/hypoglycemia * Fever * Pressure sores * Urinary complications For each, explain what the ER/ward medical officer should recognize and do initially. ## PART 10 — REFERRAL AND TRANSFER Since the described patient was referred to a higher center for CT, explain: * When transfer is appropriate * What must be stabilized before transfer * What information should accompany the patient * Why “time last known well” is critical * Medication history * Anticoagulant history * BP * GCS/NIHSS * Blood glucose * IV access * Imaging availability * Need for stroke/neurosurgical/neurointerventional capability Create a concise **stroke transfer checklist**. ## PART 11 — APPLY THE KNOWLEDGE TO THIS 75-YEAR-OLD PATIENT Give a case-specific analysis. Use only the facts supplied. State: ### Most likely preliminary diagnosis: Suspected acute stroke with severe left hemiplegia and dysarthria, subtype not yet determined. Then explain: * Why this is a medical emergency * What information is missing * What examination should be performed * What should be done immediately * Why CT is urgent * What findings would indicate ischemic stroke * What findings would indicate hemorrhagic stroke * What would determine thrombolysis eligibility * What would determine thrombectomy eligibility * What would require neurosurgical referral Do not invent BP, NIHSS, onset time, CT findings, or comorbidities. ## PART 12 — FINAL ER FLOWCHART Finish with a compact practical algorithm: **SUSPECTED STROKE** ↓ **ABC + glucose + vitals + IV access + cardiac monitoring** ↓ **Determine last-known-well** ↓ **NIHSS + focused neurological examination** ↓ **Urgent non-contrast CT ± CTA** ↓ **HEMORRHAGE?** If YES: → ICH pathway → BP control → anticoagulant reversal if indicated → neurosurgery/neurocritical care → repeat imaging/monitoring If NO: → Ischemic stroke pathway → assess thrombolysis eligibility → assess LVO/thrombectomy eligibility → reperfusion if eligible → antiplatelet and secondary prevention when appropriate → stroke-unit care ## IMPORTANT SAFETY REQUIREMENTS 1. Do not invent missing clinical information. 2. Clearly distinguish “suspected diagnosis” from “confirmed diagnosis.” 3. Use current guideline-based recommendations. 4. Give exact drug doses only when supported by current guidelines. 5. Clearly state contraindications and important exceptions. 6. Highlight time-sensitive decisions. 7. Do not recommend aspirin before hemorrhage has been excluded. 8. Do not recommend thrombolysis before appropriate brain imaging and eligibility assessment. 9. Do not delay reperfusion therapy unnecessarily for investigations that are not required. 10. Clearly explain that local stroke-center protocols may differ and specialist consultation is required. 11. Highlight situations requiring immediate neurology, neurosurgery, or neurointerventional consultation. 12. Include references to the major guidelines used. 13. Make the final note useful to a medical officer working in a resource-limited Emergency Department, including what to do when CT is available only at a higher referral center. Use clear headings, tables, algorithms, bullet points, and practical bedside language.

Searching the Web

2026 AHA ASA acute ischemic stroke guideline mechanical thrombectomy time window large core ASPECTS extended window recommendations

Searching the Web

2022 AHA ASA spontaneous intracerebral hemorrhage guideline blood pressure target systolic 140 anticoagulant reversal andexanet idarucizumab

Finding Sources
Finding Sources

Acute Stroke in the Emergency Department: Ischemic vs Hemorrhagic Stroke

Educational note for a medical officer working in an Emergency Department. Guideline-based, updated to the 2026 AHA/ASA Guideline for the Early Management of Patients With Acute Ischemic Stroke (replacing the 2018/2019 guideline) and the 2022 AHA/ASA Guideline for the Management of Spontaneous Intracerebral Hemorrhage. This is a teaching resource, not a substitute for local protocol, neurology/neurosurgery consultation, or specialist judgment.

PART 1 — Clinical Diagnosis of This Patient

Working diagnosis: "Suspected acute cerebrovascular accident presenting with severe left hemiplegia and dysarthria — stroke subtype pending urgent neuroimaging."
  1. Most appropriate preliminary diagnosis — an acute focal neurological deficit of sudden onset in a 75-year-old is, by definition, a stroke until proven otherwise. It cannot yet be called "ischemic" or "hemorrhagic" — that distinction is radiological, not clinical.
  2. Neurological syndrome — complete (0/5) left upper and lower limb weakness with dysarthria describes a dense left hemiplegia, almost always from a lesion involving the corticospinal tract, most commonly at the level of the cerebral hemisphere (cortex/subcortical white matter, internal capsule, or basal ganglia) or occasionally the brainstem.
  3. Side of brain affected — the deficit is contralateral to the lesion because corticospinal fibers decussate in the medulla. Left-sided weakness therefore localizes to the right cerebral hemisphere (or right brainstem, less likely given the pattern described).
  4. Vascular territories to consider — dense proportional hemiplegia affecting face, arm, and leg equally with dysarthria (rather than aphasia) is classic for a subcortical/deep lesion: lacunar-type infarct or hemorrhage in the posterior limb of the internal capsule, corona radiata, basal ganglia (putamen), or thalamus, where motor fibers are tightly packed. A proximal right MCA (M1) territory occlusion can also produce dense hemiplegia, usually with additional cortical signs (neglect, gaze deviation, homonymous hemianopia) if present — information not yet available here. Basal ganglia/thalamic/putaminal hemorrhage is also a leading cause of exactly this presentation in a 75-year-old, particularly if hypertensive.
  5. Can ischemic and hemorrhagic stroke be distinguished clinically? No — not reliably. Clinical scores (e.g., Siriraj, Guy's Hospital score) exist but are not accurate enough to guide treatment. Headache, vomiting, and depressed consciousness are more common in hemorrhage but occur in large ischemic strokes too, and small hemorrhages can be clinically silent aside from the focal deficit. Non-contrast CT head is mandatory before any antithrombotic or thrombolytic decision.
  6. Stroke mimics to consider — hypoglycemia, seizure with postictal (Todd's) paresis, complicated migraine, hypertensive encephalopathy, subdural hematoma/traumatic brain injury, brain tumor with acute bleed or edema, functional (psychogenic) weakness, hyponatremia/metabolic encephalopathy, sepsis "unmasking" an old deficit, and Bell's palsy/peripheral causes for the facial component if isolated. A capillary glucose and basic history exclude several of these within seconds.
  7. Immediately required additional history/examination: exact last known well time, GCS, pupils, full NIHSS (facial weakness, sensory loss, aphasia vs dysarthria, visual fields, ataxia, neglect), vital signs, glucose, history of hypertension/diabetes/atrial fibrillation/IHD/prior stroke, current antiplatelet/anticoagulant use, recent surgery/trauma/bleeding, seizure at onset, and pre-stroke functional baseline (modified Rankin Scale).

PART 2 — First 10–15 Minutes in the ER

Sequence: ABCDE → glucose → focused neuro exam → last-known-well → BP → IV access → bloods → urgent CT → reperfusion decision
StepBedside actionRationale
A – AirwayAssess for airway compromise (reduced GCS, bulbar weakness, vomiting). Positioning, suction, consider airway adjuncts/intubation if GCS very low or losing airway reflexesDepressed consciousness is common in large strokes/ICH and risks aspiration
B – BreathingRespiratory rate, SpO2, give supplemental O2 only if SpO2 <94% (do not routinely give O2 to normoxic patients)Hyperoxia is not beneficial; hypoxia worsens the ischemic penumbra
C – CirculationPulse, rhythm, BP in both arms, cardiac monitor/ECGAF is a major cardioembolic source; irregular pulse changes secondary prevention plan
Cardiac monitoringContinuous ECG from arrivalDetects AF, ischemia, arrhythmia-related hypoperfusion
IV accessTwo IV lines (one is minimum; two preferred if thrombolysis anticipated)Needed for bloods, thrombolytic infusion, and any resuscitation
Capillary glucoseImmediately, before or alongside neuro examHypoglycemia is a reversible stroke mimic and must be corrected immediately
TemperatureCheck and documentFever worsens ischemic outcome and needs treatment/source-seeking
BPMeasure, do not treat aggressively yet (see Part 7)Guides thrombolysis eligibility and BP-lowering strategy
GCS + pupilsQuick, repeatable, prognosticFalling GCS or unequal/blown pupil suggests herniation — call for help immediately
Focused neuro exam / NIHSSFace, arm, leg, speech (dysarthria vs aphasia), sensation, visual fields, neglect, ataxiaStandardizes severity, guides eligibility, and is a baseline for change
Last known well (LKW)Ask the patient, family, EMS, bystanders precisely — "asleep and normal at 9pm, found weak at 6am" = LKW is 9pm, not 6amThis single data point often determines whether reperfusion therapy is even possible
Medication/comorbidity historyAnticoagulants (warfarin/DOAC and last dose), antiplatelets, recent surgery/GI bleed/trauma, prior stroke/TIA, HTN, DM, AF, IHDDirectly changes contraindication assessment for thrombolysis
Baseline functionPre-stroke mRS/independenceAffects thrombectomy and thrombolysis candidacy in the elderly
Seizure at onsetAsk witnessesTodd's paresis is a mimic; seizure doesn't exclude stroke but changes interpretation
What must NOT delay CT/reperfusion decision: waiting for a full coagulation panel in a patient with no anticoagulant history, waiting for troponin, waiting for a chest X-ray, waiting for urine output/Foley placement, or extensive family history-taking. Glucose and a non-contrast CT are essentially the only tests that must precede thrombolysis in most patients — everything else runs in parallel, not in series.

PART 3 — Ischemic vs Hemorrhagic Stroke: Comparison

FeatureIschemic StrokeHemorrhagic Stroke (ICH)
PathophysiologyArterial occlusion (thrombotic/embolic) → regional hypoperfusion → infarctionRupture of a small penetrating artery (hypertensive, amyloid) or vascular malformation → hematoma with mass effect
OnsetSudden, often stepwise or maximal at onsetSudden, may progress over minutes-hours as hematoma expands
HeadacheLess common (more common with large or posterior circulation strokes)Common, especially with larger bleeds
VomitingLess common unless posterior circulation/large territoryCommon
Level of consciousnessPreserved unless large territory/brainstem/bilateralOften reduced, especially with large or deep bleeds, IVH
Focal deficitYes, corresponds to vascular territoryYes, may not respect vascular boundaries
SeizureUncommon at onsetMore common at onset, especially lobar ICH
Blood pressureOften elevated (reactive)Often markedly elevated
CT findingsOften normal in first hours; may show hyperdense artery sign, loss of grey-white differentiation, hypodensity laterHyperdense (bright) lesion visible immediately
MRI findingsDWI restriction (early, sensitive)Blooming on susceptibility-weighted/GRE sequences
Initial treatmentReperfusion assessment (thrombolysis/thrombectomy) if eligibleSupportive, BP control, reversal of anticoagulation, possible surgery
BP approachPermissive unless thrombolysis candidate (Part 7)Active, rapid, smooth lowering to ~140 mmHg SBP
AntiplateletAspirin after hemorrhage excluded, timing depends on thrombolysisContraindicated acutely; withhold
AnticoagulationAvoided acutely; resumed later for secondary prevention (e.g., AF)Reverse immediately if patient is on one
ThrombolysisIndicated if eligibleAbsolutely contraindicated
Mechanical thrombectomyIndicated for LVO within criteriaNot applicable
Neurosurgical roleRare (decompressive hemicraniectomy for malignant edema)Common — evacuation for cerebellar bleeds, EVD for hydrocephalus/IVH
Major complicationsEdema, hemorrhagic transformation, herniation, aspiration, seizureHematoma expansion, IVH, hydrocephalus, herniation, seizure
Key teaching point: clinical features overlap substantially. There is no clinical sign or combination of signs sufficiently accurate to replace neuroimaging. CT is mandatory before any treatment decision.

PART 4 — Investigations

Immediate imaging

  • Non-contrast CT head — the single most important, time-critical test. Distinguishes hemorrhage (hyperdense) from ischemia (often subtle or normal early).
  • CT angiography (CTA head/neck) — performed alongside NCCT whenever thrombectomy is being considered, to identify large-vessel occlusion (LVO: ICA, M1, and selected M2, basilar artery). The 2026 AHA/ASA guideline supports CTA as part of the initial imaging bundle for any patient with a disabling deficit and no contraindication.
  • CT perfusion / advanced imaging (CTP, MR DWI-FLAIR, DWI-PWI) — used for patients presenting in extended windows (beyond 4.5–9 h for thrombolysis, or 6–24 h for thrombectomy) to identify salvageable "penumbra" versus completed infarct core (mismatch imaging), per EXTEND, TRACE-3, DAWN, DEFUSE-3, SELECT2, ANGEL-ASPECT trial paradigms incorporated into the 2026 guideline.
  • MRI/DWI — more sensitive than CT for early infarct and posterior circulation/brainstem strokes, but should not delay thrombolysis decisions where CT suffices and MRI is not immediately available.
  • ECG — looks for AF, ischemia; continuous cardiac monitoring for at least the first 24 hours.

Laboratory

  • Capillary/serum glucose (mandatory, immediate)
  • CBC/platelets — thrombocytopenia is a thrombolysis contraindication
  • Electrolytes, renal function — baseline, contrast consideration for CTA
  • PT/INR, aPTT — mandatory only if patient is on warfarin/heparin, has known coagulopathy, or history is unreliable/unavailable
  • Liver function — if relevant clinically
  • Troponin — if cardiac symptoms or ECG changes
  • Type and screen — if surgery (evacuation) anticipated
Critical point for thrombolysis timing: the 2026 guideline and preceding evidence emphasize that thrombolysis should not be delayed awaiting coagulation studies in patients with no history of anticoagulant use, no suspected coagulopathy, and no thrombocytopenia risk factors — glucose and non-contrast CT are usually the only mandatory pre-thrombolysis tests. If the patient is on a DOAC/warfarin or history is unobtainable, appropriate coagulation testing (INR, aPTT, or DOAC level where available) is required before thrombolysis.
What the CT should specifically be read for:
  • Any acute intracranial hemorrhage (intraparenchymal, subarachnoid, subdural, intraventricular)
  • Early ischemic changes: loss of grey-white differentiation, insular ribbon sign, sulcal effacement
  • Hyperdense (dot/artery) sign suggesting thrombus in MCA or basilar artery
  • Established large infarction (already hypodense, established territory)
  • Mass effect, midline shift, effacement of cisterns
  • Hydrocephalus
  • Alternative structural causes: tumor, abscess, prior surgery, arteriovenous malformation clues
ASPECTS (Alberta Stroke Program Early CT Score): a 10-point scoring system on NCCT (MCA territory) used to quantify the extent of early ischemic change; scores are used to select patients for thrombectomy, including in the extended and large-core windows (ASPECTS 3–5 now included in the 2026 guideline based on SELECT2/ANGEL-ASPECT/TESLA trial data). CTA is essential whenever LVO/thrombectomy candidacy is being assessed — it should not be deferred simply because NCCT is unremarkable.

PART 5 — Acute Ischemic Stroke Management

Pathway: CT excludes hemorrhage → determine time from last known well → assess IV thrombolysis eligibility → CTA for LVO → assess thrombectomy eligibility.

A. IV Thrombolysis (2026 AHA/ASA AIS Guideline)

ParameterRecommendation
Preferred agentsTenecteplase or alteplase — the 2026 guideline now recommends either agent (previously alteplase was primary, tenecteplase an alternative)
Tenecteplase dose0.25 mg/kg IV, maximum 25 mg, given as a single IV push
Alteplase dose0.9 mg/kg IV, maximum 90 mg — 10% as bolus, remainder infused over 60 minutes
Standard windowWithin 4.5 hours of symptom onset/last known well
Extended window4.5–9 hours (or wake-up strokes) may be reasonable in selected patients with salvageable tissue demonstrated on advanced imaging (CTP or MRI mismatch), based on EXTEND and TRACE-3 trial evidence now incorporated into the 2026 guideline
Eligibility principleTreat based on disabling deficit, regardless of exact NIHSS number — do not withhold from patients with "mild" deficits if disabling
Key contraindicationsActive/recent intracranial hemorrhage, suspected SAH, recent major surgery/trauma, active internal bleeding, severe uncontrolled hypertension, therapeutic anticoagulation with elevated INR/abnormal coagulation, low platelets, hypodensity/established infarct >1/3 MCA territory on CT (relative), seizure at onset with residual impairment attributable to postictal state (relative)
BP before treatmentMust be <185/110 mmHg; treat with IV agents (labetalol, nicardipine) if above this and only give thrombolysis once controlled
BP after treatmentMaintain <180/105 mmHg for at least the first 24 hours
Deterioration during/after infusionStop infusion immediately, obtain emergent non-contrast CT head to exclude symptomatic intracranial hemorrhage, check fibrinogen/coagulation, treat as below
Symptomatic ICH after thrombolysisStop infusion, urgent CT, give cryoprecipitate and/or tranexamic acid/antifibrinolytic per local protocol, correct coagulopathy, urgent neurosurgical/neurology consultation, aggressive BP control

B. Mechanical Thrombectomy (EVT)

  • Indicated for confirmed large-vessel occlusion (ICA, M1, selected M2) on CTA, and now, per the 2026 guideline, basilar artery occlusion within 24 hours with NIHSS ≥10 (ATTENTION/BAOCHE evidence).
  • Standard window: up to 6 hours by NIHSS/ASPECTS ≥6 selection.
  • Extended window (6–24 hours): requires advanced imaging (CTP or MR DWI-FLAIR/PWI mismatch) demonstrating salvageable tissue — based on DAWN/DEFUSE-3 and now extended further.
  • Large-core infarcts (ASPECTS 3–5): now a reasonable (Class 2) indication for EVT in eligible patients under 80 with good pre-stroke functional status (mRS 0–1/2) and no significant mass effect, based on SELECT2, ANGEL-ASPECT, and TESLA trials.
  • CTA is required before EVT can be planned — do not send a patient for thrombectomy assessment without vessel imaging.
  • EVT should not be delayed while awaiting the effect of IV thrombolysis, and IV thrombolysis (if eligible) should not be withheld to "wait for" thrombectomy — eligible patients should receive both where indicated, in parallel ("drip and ship" or "drip and drive").

C. Patients NOT Receiving Reperfusion Therapy

  • Aspirin 160–325 mg orally or via NG tube, started within 24–48 hours, once hemorrhage has been excluded on CT.
  • Do NOT give aspirin if: hemorrhage has not yet been excluded, thrombolysis was given (wait 24 hours and repeat CT first), or the patient will require imminent surgery/procedure with bleeding risk.
  • BP: permissive approach (see Part 7); avoid aggressive lowering.
  • Maintain euvolemia; avoid hypotonic fluids.
  • Treat glucose if persistently elevated (2026 guideline favors less intensive glycemic targets than previously, avoiding hypoglycemia).
  • Treat fever; avoid hyperthermia.
  • Formal swallow screen before any oral intake — nothing by mouth until screened.
  • DVT prophylaxis: intermittent pneumatic compression from admission; pharmacologic prophylaxis once hemorrhage excluded and patient is immobile.
  • Supplemental oxygen only if hypoxic.
  • Early mobilization and rehabilitation referral once stable.

PART 6 — Acute Intracerebral Hemorrhage Management (2022 AHA/ASA ICH Guideline)

  1. ABC stabilization — airway protection is a priority given frequent depressed consciousness.
  2. Admit to a stroke unit or neurocritical care unit — outcomes are improved with specialized care.
  3. Blood pressure — for SBP 150–220 mmHg presenting within 6 hours, acutely lower to a target SBP of ~140 mmHg (acceptable range 130–150), achieved smoothly within the first hour and sustained without large variability, using titratable IV agents (nicardipine, labetalol). Avoid abrupt drops below ~130 mmHg. Evidence base: INTERACT2, ATACH-2.
  4. Repeat neurological assessment — frequent GCS/NIHSS; any decline triggers urgent repeat imaging.
  5. Anticoagulant reversal — immediate, drug-specific (see table below).
  6. Antiplatelet agents — routine platelet transfusion is not recommended for ICH patients on antiplatelets without planned surgery (evidence of harm/no benefit); withhold future antiplatelets acutely.
  7. Neurosurgical consultation — early, especially for cerebellar hemorrhage, hydrocephalus, large lobar hematomas with mass effect, or declining GCS.
  8. ICP management when indicated: head of bed elevation, analgesia/sedation, osmotherapy (mannitol/hypertonic saline), avoid hyperventilation except as a temporizing bridge, EVD if hydrocephalus.
  9. Hydrocephalus — from IVH or mass effect obstructing CSF flow — requires urgent EVD placement.
  10. Cerebellar hemorrhage — low threshold for surgical evacuation if diameter >3 cm, brainstem compression, or hydrocephalus/deteriorating consciousness — this is a neurosurgical emergency.
  11. Intraventricular hemorrhage (IVH) — associated with worse prognosis; consider EVD; intraventricular thrombolysis is investigational, not routine.
  12. Seizures — treat clinical seizures with standard antiseizure medication; routine/prophylactic antiseizure medication in patients without seizures is not recommended (uncertain benefit per 2022 guideline).
  13. DVT prophylaxis — intermittent pneumatic compression from day 1; pharmacologic prophylaxis can typically start once hemorrhage stability is confirmed on repeat imaging (usually after 24–48 hours), per local protocol.
  14. Repeat CT imaging — usually at 6–24 hours or with any clinical deterioration, to detect hematoma expansion.
  15. Nutrition/swallowing — formal dysphagia screening before oral intake; early enteral nutrition if unable to swallow safely.
  16. Rehabilitation — early multidisciplinary involvement once medically stable.
Anticoagulant reversal — drug specific:
DrugReversal
Warfarin4-factor prothrombin complex concentrate (PCC) plus IV vitamin K
DabigatranIdarucizumab (specific reversal agent)
Apixaban / Rivaroxaban (factor Xa inhibitors)Andexanet alfa (Class 2a) or 4-factor PCC (Class 2b, when andexanet unavailable)
Other factor Xa inhibitors (edoxaban)4-factor PCC generally used given limited andexanet data
Heparin (unfractionated/LMWH)Protamine sulfate
Practices the 2022 guideline explicitly does NOT support (avoid using routinely): prophylactic antiseizure medication without seizures, routine platelet transfusion for antiplatelet-associated ICH without planned surgery, and corticosteroids for ICH-related edema — these have uncertain benefit or evidence of harm.

PART 7 — Blood Pressure Management by Situation

SituationBP threshold/targetApproach
Suspected ischemic stroke, not receiving reperfusion therapyPermissive up to ~220/120 mmHgGenerally do not treat unless another emergency (see below) coexists; avoid aggressive lowering — it can extend the ischemic penumbra
Ischemic stroke, eligible for thrombolysis, before treatmentMust be <185/110 mmHgIV labetalol or nicardipine to get below threshold; give thrombolysis only once achieved
After thrombolysisMaintain <180/105 mmHg for ≥24 hoursFrequent monitoring (Part 8); titratable IV agents
Before mechanical thrombectomyGenerally <185/110 mmHg if thrombolysis also planned; otherwise per local/interventional protocolCoordinate with interventional team
After successful thrombectomyIndividualized; often <160/90 mmHg (higher targets if incomplete reperfusion)Per interventionalist/neurologist guidance — avoid hypotension risking hypoperfusion
Intracerebral hemorrhage, SBP 150–220 within 6hTarget SBP ~140 mmHg (range 130–150), achieved within 1 hour, smooth/sustainedIV nicardipine or labetalol infusion, avoid large swings
BP elevated due to a concurrent emergency (aortic dissection, ACS, acute pulmonary edema, hypertensive encephalopathy)Treat per that emergency's targetsManage the competing emergency but coordinate with stroke team — do not let one pathway blindly override safety in the other
Why excessive lowering is dangerous in ischemic stroke: the ischemic penumbra depends on collateral perfusion pressure; dropping BP too far can convert salvageable tissue into infarct, worsening the deficit. In ICH, however, controlled and sustained lowering reduces hematoma expansion and is beneficial — the two conditions are managed in opposite directions, which is exactly why imaging must precede any BP-lowering decision.

PART 8 — Monitoring Checklist (ER and Stroke Unit)

ParameterFrequency (typical)
BPEvery 15 min x2h → every 30 min x6h → hourly thereafter (tighter if post-thrombolysis, see below)
GCS/NIHSSEvery 15–30 min in first 2 hours, then hourly for 24h in acute cases
PupilsWith each neuro check
SpO2Continuous
Heart rhythmContinuous ECG for at least 24h (AF detection)
GlucoseEvery 4–6 h initially, more often if abnormal
TemperatureEvery 4 h; treat fever promptly
Fluid balance/urine outputHourly to 4-hourly
Swallow statusBefore any oral intake, reassess if consciousness changes
Signs of aspirationOngoing clinical observation
Signs of cerebral edema/herniationNew pupil asymmetry, falling GCS, posturing, bradycardia with hypertension (Cushing reflex)
Neurological deteriorationAny NIHSS increase ≥2–4 points warrants urgent repeat CT
Seizure activityContinuous clinical observation
Hemorrhagic transformationSuspect with any deterioration post-thrombolysis or in large infarcts
DVT/PEDaily leg checks, prophylaxis compliance, watch for tachycardia/hypoxia
Pressure injuriesRegular repositioning, skin checks every shift
Post-thrombolysis special monitoring (standard protocol):
  • Neuro checks and BP every 15 minutes for 2 hours, then every 30 minutes for 6 hours, then hourly until 24 hours post-infusion.
  • No antiplatelet/anticoagulant agents, no NG tube placement, no urinary catheterization, and no arterial puncture for 24 hours unless clinically essential, to minimize bleeding risk.
  • Any acute headache, sudden BP rise, nausea/vomiting, or neurological worsening → stop any ongoing infusion, get emergent non-contrast CT immediately.

PART 9 — Complications: Recognition and Initial Action

ComplicationRecognizeInitial ER/ward action
Cerebral edema/herniationFalling GCS, new pupil asymmetry, posturing, Cushing's triadHead-up 30°, urgent CT, osmotherapy, urgent neurosurgery/neurocritical care call
Hemorrhagic transformationNeuro deterioration, especially post-thrombolysis or large infarctStop antithrombotics, urgent CT, coagulation correction if on thrombolysis
Aspiration pneumoniaFever, hypoxia, new infiltrate, prior failed swallow screenNBM until screened, chest imaging, antibiotics if pneumonia confirmed
DysphagiaFailed bedside swallow screenKeep NBM, NG feeding, speech-language pathology referral
SeizureWitnessed convulsion or subtle motor automatismsABCs, benzodiazepine if prolonged, treat only clinical seizures (not prophylactic)
DVT/PELeg swelling, tachycardia, hypoxia, chest painMechanical prophylaxis from day 1; investigate and treat per usual DVT/PE protocol once hemorrhage stability allows anticoagulation
Arrhythmia (esp. AF)Continuous ECG monitoring, irregular pulseRate control if unstable, cardiology input, informs secondary prevention
Acute coronary syndromeChest pain, ECG changes, troponin riseECG, troponin, cardiology involvement, balance with bleeding risk of any planned reperfusion
Hyper/hypoglycemiaRegular glucose checksCorrect hypoglycemia immediately (mimic/worsens deficit); treat persistent hyperglycemia with moderate, not overly tight, control
FeverTemperature checksIdentify and treat source, antipyretics, avoid untreated hyperthermia
Pressure soresSkin checksRegular repositioning, pressure-relief surfaces
Urinary complications (retention/infection)Bladder scan, urine output, dipstickAvoid unnecessary catheterization (especially post-thrombolysis); intermittent catheterization preferred if retention

PART 10 — Referral and Transfer

When transfer is appropriate: any suspected acute stroke at a facility without CT, or without thrombectomy/neurosurgical capability when imaging suggests LVO or a surgical hemorrhage, should be transferred urgently to a comprehensive stroke center — this is exactly the situation described in the case (patient referred for CT).
Before transfer, stabilize:
  • Airway secured if at risk
  • Oxygenation adequate
  • BP addressed only if there is a competing emergency, or already known thrombolysis threshold exceeded
  • IV access secured (ideally two lines)
  • Glucose corrected if abnormal
  • Seizures controlled if occurring
Information that must accompany the patient (Stroke Transfer Checklist):
  • Exact last known well time (single most important data point — determines eligibility windows)
  • Time of symptom onset/discovery and who witnessed it
  • Full vital signs trend (BP, HR, SpO2, temperature) with timestamps
  • GCS and NIHSS (or at minimum a clear description of the deficit) with time recorded
  • Blood glucose result(s)
  • Anticoagulant/antiplatelet history, drug names, last dose and time
  • Comorbidities: hypertension, diabetes, AF, IHD, prior stroke/TIA
  • Pre-stroke functional status/independence (mRS)
  • Recent surgery, trauma, or bleeding history
  • IV access confirmed patent
  • Any medication already given (including any thrombolytic if started, and time)
  • Receiving center confirmed as having CT/CTA, thrombectomy, and neurosurgical/neurocritical capability as needed
  • Family/next-of-kin contact information for consent discussions
Why last known well is critical: every reperfusion decision (thrombolysis window, thrombectomy window, extended-window imaging eligibility) is calculated from this single time point — an inaccurate or vague LKW can wrongly exclude a treatable patient or wrongly include an ineligible one.
Resource-limited setting note: where CT is only available at a higher center, do not delay transfer to obtain tests that will be repeated there (e.g., don't wait on a local low-yield workup). Send the patient as soon as safely transportable, with the checklist above, and call ahead so the receiving stroke team can prepare (pre-notification/"code stroke" call).

PART 11 — Applying the Knowledge to This 75-Year-Old Patient

Facts available: 75-year-old male, sudden left-sided weakness (0/5 upper and lower limb), slurred speech, referred for CT. Facts not available: onset/last known well time, vitals, glucose, GCS, NIHSS, pupils, facial weakness, sensory findings, aphasia vs dysarthria clarification, visual fields, ataxia, comorbidities (HTN, DM, AF, IHD, prior stroke), antiplatelet/anticoagulant use, recent surgery/bleeding, seizure, trauma, baseline function, and CT findings.
Most likely preliminary diagnosis: Suspected acute stroke with severe left hemiplegia and dysarthria, subtype not yet determined.
  • Why this is a medical emergency: dense hemiplegia in an elderly patient represents either a large-vessel ischemic stroke (time-critical for thrombolysis/thrombectomy) or a significant hemorrhage (time-critical for BP control, reversal, and possible surgery). Every minute of delay in either pathway worsens outcome ("time is brain").
  • What information is missing: essentially the entire eligibility dataset — timing, vitals, glucose, severity score, comorbidities, medications, and above all, imaging. None of this should be assumed.
  • What examination should be performed: full ABCDE, GCS, pupils, complete NIHSS (face, arm, leg, sensory, visual fields, neglect, speech classification), vital signs, glucose, and a directed history from family/EMS focused on exact last known well time and anticoagulant/antiplatelet use.
  • What should be done immediately: ABC stabilization, glucose check, IV access, cardiac monitoring, and expedited transfer/movement to CT with pre-notification of the receiving stroke team, carrying the transfer checklist above.
  • Why CT is urgent: it is the only way to distinguish ischemia from hemorrhage, and this determines whether the patient proceeds toward thrombolysis/thrombectomy or toward BP control/anticoagulant reversal/possible neurosurgery — two management pathways that are opposite in their BP strategy and antithrombotic use.
  • Findings that would indicate ischemic stroke: normal or subtly hypodense CT (or early ischemic changes/hyperdense vessel sign), no hemorrhage, with the clinical deficit correlating to a vascular territory (right MCA/subcortical distribution given left hemiplegia).
  • Findings that would indicate hemorrhagic stroke: a hyperdense (bright) lesion on CT, most likely in the right basal ganglia/thalamus/internal capsule region given the dense proportional hemiplegia, possibly with intraventricular extension, mass effect, or midline shift.
  • What determines thrombolysis eligibility: confirmed absence of hemorrhage, time from last known well (within 4.5 h standard, or 4.5-9 h with qualifying advanced imaging per the 2026 guideline), no contraindications (no recent bleeding/surgery/trauma, no therapeutic anticoagulation with abnormal coagulation, no severe uncontrolled hypertension >185/110 unresponsive to treatment, platelets adequate).
  • What determines thrombectomy eligibility: CTA demonstrating a large-vessel occlusion (right ICA/M1 given the presentation), a favorable ASPECTS or advanced-imaging profile (including large-core patients now potentially eligible per 2026 criteria), a disabling deficit, reasonable pre-stroke functional status, and presentation within the applicable time window (up to 24 hours in selected imaging-qualified patients).
  • What would require neurosurgical referral: if CT shows intracerebral hemorrhage with significant mass effect, midline shift, hydrocephalus, intraventricular extension, cerebellar location, or clinical deterioration/rising ICP signs.
No BP, NIHSS, onset time, CT findings, or comorbidities are invented in this analysis — they remain unknown pending full assessment and imaging.

PART 12 — Final ER Flowchart

SUSPECTED STROKE
      ↓
ABC + glucose + vitals + IV access + cardiac monitoring
      ↓
Determine last-known-well (critical, do not skip)
      ↓
NIHSS + focused neurological examination
      ↓
Urgent non-contrast CT ± CTA
      ↓
   HEMORRHAGE?
   ┌───────────────┴───────────────┐
  YES                              NO
   ↓                                ↓
ICH PATHWAY                    ISCHEMIC STROKE PATHWAY
- BP control (target SBP        - Assess IV thrombolysis eligibility
  ~140 mmHg within 1h)             (time window + no contraindication)
- Reverse anticoagulation        - Give tenecteplase 0.25 mg/kg (max 25mg)
  if indicated (drug-specific)     OR alteplase 0.9 mg/kg (max 90mg) if eligible
- Neurosurgery / neurocritical  - Assess LVO via CTA → thrombectomy eligibility
  care consultation                (up to 24h in selected imaging-qualified patients)
- Repeat imaging/monitoring     - Reperfuse if eligible (IVT + EVT can combine)
- No antiplatelets/thrombolysis - If not eligible for reperfusion: aspirin
                                   (once hemorrhage excluded), BP permissive,
                                   DVT prophylaxis, swallow screen
                                 - Stroke-unit admission, secondary prevention workup

Key References Used

  • 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke — AHA/ASA, Stroke 2026 (replaces 2018 guideline/2019 update).
  • 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage — AHA/ASA, Stroke 2022 (Greenberg et al.).
  • Supporting trial evidence referenced within the 2026 guideline: EXTEND, TRACE-3 (extended thrombolysis window); DAWN, DEFUSE-3, SELECT2, ANGEL-ASPECT, TESLA, RESCUE-LIMIT (extended/large-core thrombectomy); ATTENTION, BAOCHE (basilar artery occlusion); ORIGINAL, NOR-TEST 2 (tenecteplase dosing).
  • Supporting trial evidence for ICH BP management: INTERACT2, ATACH-2.
  • NIHSS reference table — Tintinalli's Emergency Medicine: A Comprehensive Study Guide; Roberts and Hedges' Clinical Procedures in Emergency Medicine.
  • General ICH management principles — Bradley and Daroff's Neurology in Clinical Practice.
Final caution: local stroke-center protocols, drug availability (tenecteplase vs alteplase, andexanet alfa availability), and institutional thresholds may differ from the recommendations above. Any real patient encounter requires timely neurology, neurosurgery, or neurointerventional consultation as appropriate to the imaging findings, and this note does not replace that clinical judgment.
This is a shared conversation. Sign in to Orris to start your own chat.